{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T06:19:35Z","timestamp":1792909175810,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,26]],"date-time":"2020-10-26T00:00:00Z","timestamp":1603670400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060236"],"award-info":[{"award-number":["82060236"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2019GXNSFDA245032"],"award-info":[{"award-number":["2019GXNSFDA245032"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2017GXNSFAA198042"],"award-info":[{"award-number":["2017GXNSFAA198042"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.msard.2020.102604","type":"journal-article","created":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T13:14:20Z","timestamp":1603804460000},"page":"102604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity"],"prefix":"10.1016","volume":"47","author":[{"given":"Yachun","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangling","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junxiang","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.msard.2020.102604_bib0001","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1474-4422(10)70253-2","article-title":"Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis","volume":"10","author":"Dalmau","year":"2011","journal-title":"Lancet Neurol"},{"issue":"9","key":"10.1016\/j.msard.2020.102604_bib0002","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1056\/NEJMra1708712","article-title":"Antibody-Mediated Encephalitis","volume":"378","author":"Dalmau","year":"2018","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.msard.2020.102604_bib0003","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S1474-4422(08)70224-2","article-title":"Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.msard.2020.102604_bib0004","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/mp.2013.110","article-title":"Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity","volume":"19","author":"Hammer","year":"2014","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.msard.2020.102604_bib0005","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.seizure.2015.04.005","article-title":"CSF findings in patients with anti-N-methyl-D-aspartate receptor-encephalitis","volume":"29","author":"Wang","year":"2015","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.msard.2020.102604_bib0006","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s12028-018-0536-6","article-title":"Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients","volume":"29","author":"Zhang","year":"2018","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.msard.2020.102604_bib0007","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jneuroim.2017.09.005","article-title":"Anti-N-methyl-D-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes","volume":"312","author":"Wang","year":"2017","journal-title":"Journal of Neuroimmunology"},{"issue":"11","key":"10.1016\/j.msard.2020.102604_bib0008","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/0883073817720340","article-title":"Comparative Outcomes in Children and Adults With Anti- N-Methyl-D-Aspartate (anti-NMDA) Receptor Encephalitis","volume":"32","author":"Gordon-Lipkin","year":"2017","journal-title":"J Child Neurol"},{"issue":"5","key":"10.1016\/j.msard.2020.102604_bib0009","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.braindev.2018.12.009","article-title":"Clinical manifestations, treatment outcomes, and prognostic factors of pediatric anti-NMDAR encephalitis in tertiary care hospitals: A multicenter retrospective\/prospective cohort study","volume":"41","author":"Pruetarat","year":"2019","journal-title":"Brain Dev"},{"issue":"4","key":"10.1016\/j.msard.2020.102604_bib0010","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.msard.2020.102604_bib0011","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.msard.2018.10.114","article-title":"Disruption of blood-brain barrier integrity associated with brain lesions in Chinese neuromyelitis optica spectrum disorder patients","volume":"27","author":"You","year":"2019","journal-title":"Mult Scler Relat Disord"},{"issue":"2","key":"10.1016\/j.msard.2020.102604_bib0012","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0022-510X(00)00501-3","article-title":"Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs","volume":"184","author":"Reiber","year":"2001","journal-title":"J Neurol Sci"},{"issue":"3","key":"10.1016\/j.msard.2020.102604_bib0013","doi-asserted-by":"crossref","first-page":"e244","DOI":"10.1212\/WNL.0000000000006783","article-title":"A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis","volume":"92","author":"Balu","year":"2019","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.msard.2020.102604_bib0014","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-Brain Barrier: From Physiology to Disease and Back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev"},{"issue":"9","key":"10.1016\/j.msard.2020.102604_bib0015","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S1474-4422(18)30244-8","article-title":"Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis","volume":"17","author":"Armangue","year":"2018","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.msard.2020.102604_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11908-017-0556-y","article-title":"NMDAR Encephalitis Following Herpes Simplex Virus Encephalitis","volume":"19","author":"Galli","year":"2017","journal-title":"Curr Infect Dis Rep"},{"issue":"4","key":"10.1016\/j.msard.2020.102604_bib0017","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1515\/CCLM.2001.052","article-title":"The intrathecal humoral immune response: laboratory analysis and clinical relevance","volume":"39","author":"Sindic","year":"2001","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.msard.2020.102604_bib0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","article-title":"Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma","volume":"61","author":"Dalmau","year":"2007","journal-title":"Ann Neurol"},{"issue":"2","key":"10.1016\/j.msard.2020.102604_bib0019","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(12)70310-1","article-title":"Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study","volume":"12","author":"Titulaer","year":"2013","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.msard.2020.102604_bib0020","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/ene.12911","article-title":"Anti-NMDA receptor encephalitis: clinical characteristics, predictors of outcome and the knowledge gap in southwest China","volume":"23","author":"Wang","year":"2016","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.msard.2020.102604_bib0021","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.intimp.2016.04.006","article-title":"Neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) were associated with disease activity in patients with systemic lupus erythematosus","volume":"36","author":"Wu","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.msard.2020.102604_bib0022","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.msard.2017.10.009","article-title":"The neutrophil-to-lymphocyte ratio as disease actvity marker in multiple sclerosis and optic neuritis","volume":"18","author":"Bisgaard","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.msard.2020.102604_bib0023","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neulet.2018.12.003","article-title":"Prediction of neutrophil-to-lymphocyte ratio in the diagnosis and progression of autoimmune encephalitis","volume":"694","author":"Zeng","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.msard.2020.102604_bib0024","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3389\/fimmu.2019.01286","article-title":"Analysis of Clinical Characteristics and Poor Prognostic Predictors in Patients With an Initial Diagnosis of Autoimmune Encephalitis","volume":"10","author":"Qiu","year":"2019","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.msard.2020.102604_bib0025","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/jnnp.2007.136473","article-title":"Neurological response to early removal of ovarian teratoma in anti-NMDAR encephalitis","volume":"79","author":"Seki","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"10.1016\/j.msard.2020.102604_bib0026","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3988\/jcn.2019.15.3.369","article-title":"Factors Affecting the Response to First-Line Treatments in Patients with Anti-N-Methyl-D-Aspartate Receptor Encephalitis","volume":"15","author":"Zhang","year":"2019","journal-title":"J Clin Neurol"},{"key":"10.1016\/j.msard.2020.102604_bib0027","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jaut.2018.10.014","article-title":"Prognosticating autoimmune encephalitis: A systematic review","volume":"96","author":"Broadley","year":"2019","journal-title":"J Autoimmun"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820306787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034820306787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T10:28:02Z","timestamp":1778840882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034820306787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":27,"alternative-id":["S2211034820306787"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2020.102604","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Clinical Features and Prognosis of Anti-NMDAR Encephalitis Depends on Blood Brain Barrier Integrity","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2020.102604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102604"}}